Biologics
TNF Inhibitors
- Humira (adalimumab) - Self-injection, typically every 2 weeks
- Remicade (infliximab) - Infusion, typically every 8 weeks
- Cimzia (certolizumab) - Self-injection, typically every 2-4 weeks
- Simponi (golimumab) - Self-injection, typically every 4 weeks
IL-12/23 Inhibitors
- Stelara (ustekinumab) - Infusion then self-injection every 8 weeks
- Skyrizi (risankizumab) - Self-injection, typically every 8 weeks
Integrin Inhibitors
- Entyvio (vedolizumab) - Infusion, typically every 8 weeks
JAK Inhibitors
- Rinvoq (upadacitinib) - Daily oral
- Xeljanz (tofacitinib) - Twice daily oral (UC only)
5-ASAs (Aminosalicylates)
- Mesalamine - Pentasa, Asacol HD, Lialda, Apriso, Delzicol
- Sulfasalazine (Azulfidine)
- Balsalazide (Colazal)
- Olsalazine (Dipentum)
Immunomodulators
- Azathioprine (Imuran, Azasan)
- 6-Mercaptopurine (Purinethol, 6-MP)
- Methotrexate (Rheumatrex, Trexall)
Corticosteroids
- Prednisone - Oral, various tapers
- Budesonide (Entocort EC, Uceris) - Oral, targeted release
- Methylprednisolone (Medrol) - Oral or IV
- Hydrocortisone - Rectal foam/enema
Antibiotics (for complications)
- Metronidazole (Flagyl)
- Ciprofloxacin (Cipro)
- Rifaximin (Xifaxan)
Supplements Commonly Tracked
- Vitamin D3
- Vitamin B12
- Iron (ferrous sulfate, ferrous gluconate)
- Folic acid
- Calcium
- Probiotics (VSL#3, Visbiome)
How Medication Tracking Works
Add your medications
Name, dose, frequency (daily, weekly, every 8 weeks, etc.)
Log when you take them
One tap, or set reminders
See real adherence
Percentages calculated automatically
Share with your GI
Included in your 1-tap report with exact percentages
Why Adherence Matters
Studies show IBD patients who maintain >80% adherence to maintenance therapy have significantly fewer flares and hospitalizations. Your GI needs to know if you're at 95% or 60%, not just "I think I missed a few doses."
Flarity gives you real numbers. Your report shows "Skyrizi adherence: 100%" or "Mesalamine adherence: 73%" - data your doctor can act on.